bluebird bio, Inc. Common Stock Nasdaq Global Select
Open: $4.35 High: $4.47 Low: $4.09 Close: $4.11
Range: 2022-06-27 - 2022-06-28
Market: Open
bluebird bio, Inc. Common Stock 60 BINNEY STREET
bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
  • CEO: Nick Leschly
  • Employees: 518
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
Latest news about the BLUE